AC6 Gene Transfer in Patients With Reduced Left Ventricular Ejection Fraction Heart Failure
Status:
Withdrawn
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
To determine the safety and efficacy of an intracoronary injection of adenovirus 5 encoding
human adenylyl cyclase 6 (RT-100) in patients with heart failure with reduced left
ventricular ejection fraction (HFrEF) in a Phase 3 clinical trial.